Back to all stories
Chlamydia trachomatis inclusion bodies (brown) in a McCoy cell culture
Photo: Leishmania_tropica_7.jpg: Pathology of infectious diseases http://info.fujita-hu.ac.jp/~tsutsumi/index.html# Trypanosoma_cruzi_crithidia.jpeg: * Photo Credit: Content Providers(s): CDC/Dr. Myron G. S | CC BY-SA 3.0 | Wikimedia Commons

CDC Reports U.S. Tuberculosis Cases Hit Highest Level Since 2013

A Fox News report citing the Centers for Disease Control and Prevention says more than 10,600 tuberculosis (TB) cases were confirmed in the U.S. in 2024, about three per 100,000 people, marking the third straight annual increase and the highest count since 2013. Infectious‑disease physician Renuga Vivekanandan attributes the rise largely to a post‑COVID 'rebound effect,' as latent TB infections that went undetected or untreated when surveillance and treatment programs were disrupted are now progressing to active disease. She also points to resumed international travel and increased migration from higher‑TB‑burden countries, combined with local and state TB programs that remain understaffed, as contributing factors. The piece explains that while U.S. incidence is still far below the global average of roughly 131 cases per 100,000, TB remains a potentially deadly airborne infection that mostly attacks the lungs and can spread when people with active pulmonary disease cough, speak or sneeze. Public‑health experts warn the trend underscores the need to rebuild TB screening and treatment capacity in the wake of the pandemic and to identify and treat latent infections before they become contagious.

Public Health and Infectious Disease CDC and Federal Health Data

📌 Key Facts

  • More than 10,600 U.S. TB cases were confirmed in 2024, about three per 100,000 people, according to CDC data.
  • The 2024 figure is the highest annual U.S. TB case count since 2013 and represents the third consecutive yearly increase after a 2020 dip.
  • Experts cited in the article say COVID‑19 disrupted TB surveillance and treatment, leading to a 'rebound effect' as latent infections become active, compounded by renewed international travel, migration from high‑TB countries, and still‑understaffed TB programs.

📰 Source Timeline (1)

Follow how coverage of this story developed over time